Chapter 11 Monitoring Mammalian Target of Rapamycin (mTOR) Activity

Methods in Enzymology

Volumn 451, Issue C, 2009, Pages 165-180

  Ikenoue, Tsuneo ^a   Hong, Sungki ^a   Inoki, Ken ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; GROWTH FACTOR; INITIATION FACTOR 4E BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; S6 KINASE; PROTEIN KINASE;

AGING; AUTOPHAGY; CANCER GROWTH; CELL CULTURE; CELL GROWTH; CELL LYSATE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUTRIENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; TISSUE PREPARATION; YEAST; ARTICLE; CELL LINE; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

MAMMALIA;

AUTOPHAGY; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN KINASES;

EID: 59249088869     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)03611-2     Document Type: Review

References (40)

1. Abraham R.T. PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair (Amst.) 3 8-9 (2004) 883-887
2. Brunn G.J., Fadden P., Haystead T.A., and Lawrence Jr. J.C. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus. J. Biol. Chem. 272 51 (1997) 32547-32550
3. Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., and Sabatini D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95 4 (1998) 1432-1437
4. Fonseca B.D., Smith E.M., Lee V.H., MacKintosh C., and Proud C.G. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J. Biol. Chem. 282 34 (2007) 24514-24524
5. Garami A., Zwartkruis F.J., Nobukuni T., Joaquin M., Roccio M., Stocker H., Kozma S.C., Hafen E., Bos J.L., and Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11 6 (2003) 1457-1466
6. Gingras A.C., Gygi S.P., Raught B., Polakiewicz R.D., Abraham R.T., Hoekstra M.F., Aebersold R., and Sonenberg N. Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev. 13 11 (1999) 1422-1437
7. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., Polakiewicz R.D., Wyslouch-Cieszynska A., Aebersold R., and Sonenberg N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15 21 (2001) 2852-2864
8. Guertin D.A., Stevens D.M., Thoreen C.C., Burds A.A., Kalaany N.Y., Moffat J., Brown M., Fitzgerald K.J., and Sabatini D.M. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11 6 (2006) 859-871
9. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., and Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 2 (2002) 177-189
10. Ikenoue T., Inoki K., Yang Q., Zhou X., and Guan K.-L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27 14 (2008) 1919-1931
11. Inoki K., Li Y., Xu T., and Guan K.-L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17 15 (2003) 1829-1834
12. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S.Y., Huang Q., Qin J., and Su B. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127 1 (2006) 125-137
13. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 2 (2002) 163-175
14. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., Oppliger W., Jenoe P., and Hall M.N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10 3 (2002) 457-468
15. Long X., Lin Y., Ortiz-Vega S., Yonezawa K., and Avruch J. Rheb Binds and Regulates the mTOR Kinase. Curr. Biol. 15 8 (2005) 702-713
16. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., Goldberg A.L., Schiaffino S., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell. Metab. 6 6 (2007) 458-471
17. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 7182 (2008) 1069-1075
18. Neufeld T.P. Contribution of Atg1-dependent autophagy to TOR-mediated cell growth and survival. Autophagy 3 5 (2007) 477-479
19. Oshiro N., Takahashi R., Yoshino K., Tanimura K., Nakashima A., Eguchi S., Miyamoto T., Hara K., Takehana K., Avruch J., Kikkawa U., and Yonezawa K. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J. Biol. Chem. 282 28 (2007) 20329-20339
20. Oshiro N., Yoshino K., Hidayat S., Tokunaga C., Hara K., Eguchi S., Avruch J., and Yonezawa K. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9 4 (2004) 359-366
21. Sabatini D.M. mTOR and cancer: Insights into a complex relationship. Nat. Rev. Cancer 6 9 (2006) 729-734
22. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., and Sabatini D.M. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1. Science 320 (2008) 1496-1501
23. Sancak Y., Thoreen C.C., Peterson T.R., Lindquist R.A., Kang S.A., Spooner E., Carr S.A., and Sabatini D.M. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25 6 (2007) 903-915
24. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 14 (2004) 1296-1302
25. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 2 (2006) 159-168
26. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 5712 (2005) 1098-1101
27. Sarbassov D.D., and Sabatini D.M. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280 47 (2005) 39505-39509
28. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 2 (2006) 159-168
29. Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., and Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and α-synuclein. J. Biol. Chem. 282 8 (2007) 5641-5652
30. Schalm S.S., and Blenis J. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12 8 (2002) 632-639
31. Schalm S.S., Fingar D.C., Sabatini D.M., and Blenis J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13 10 (2003) 797-806
32. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 2 (2000) 253-262
33. Shiota C., Woo J.T., Lindner J., Shelton K.D., and Magnuson M.A. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11 4 (2006) 583-589
34. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., and Blenis J. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13 15 (2003) 1259-1268
35. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., and Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9 3 (2007) 316-323
36. Wang L., Harris T.E., and Lawrence Jr. J.C. Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated phosphorylation. J. Biol. Chem. 283 23 (2008) 15619-15627
37. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4 5 (2008) 295-305
38. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 3 (2006) 471-484
39. Yang Q., Inoki K., Kim E., and Guan K.-L. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc. Natl. Acad. Sci. USA 103 18 (2006) 6811-6816
40. Zhang Y., Gao X., Saucedo L.J., Ru B., Edgar B.A., and Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell. Biol. 5 6 (2003) 578-581